Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells

Yunhao Chen, Low Teck Yew, Lee Yee Choong, Rajarshi Sankar Ray, Yee Ling Tan, Weiyi Toy, Qingsong Lin, Keong Ang Boon, Hong Wong Chee, Simin Lim, Bin Li, Choy Leong Hew, Newman Siu Kwan Sze, Brian J. Druker, Yoon Pin Lim

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

With the completion of the human genome project, analysis of enriched phosphotyrosyl proteins from epidermal growth factor (EGF)-induced phosphotyrosine proteome permits the identification of novel downstream substrates of the EGF receptor (EGFR). Using cICAT-based LC-MS/MS method, we identified and relatively quantified the tyrosine phosphorylation levels of 21 proteins between control and EGF-treated A431 human cervical cancer cells. Of these, Endofin, DCBLD2, and KIAA0582 were validated to be novel tyrosine-phosphorylation targets of EGF signaling and Iressa, a highly selective inhibitor of EGFR. In addition, EGFR activity was shown to be necessary for EGF-induced localization of Endofin, an FYVE domain-containing protein regulated by phosphoinositol lipid and engaged in endosome-mediated receptor modulation. Although several groups have conducted phosphoproteomics of EGF signaling in recent years, our study is the first to identify and validate Endofin, DCBLD2, and KIAA0582 as part of a complex EGF phosphotyrosine signaling network. These novel data will provide new insights into the complex EGF signaling and may have implications on target-directed cancer therapeutics.

Original languageEnglish
Pages (from-to)2384-2397
Number of pages14
JournalProteomics
Volume7
Issue number14
DOIs
Publication statusPublished - 1 Jul 2007
Externally publishedYes

Fingerprint

Phosphorylation
Epidermal Growth Factor
Tyrosine
Cells
Epidermal Growth Factor Receptor
Neoplasms
Phosphotyrosine
Human Genome Project
Proteins
Endosomes
Proteome
gefitinib
Uterine Cervical Neoplasms
Genes
Modulation
Lipids
Substrates

Keywords

  • cICAT
  • DCBLD2
  • EGF
  • Endofin
  • Iressa

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells. / Chen, Yunhao; Teck Yew, Low; Choong, Lee Yee; Ray, Rajarshi Sankar; Tan, Yee Ling; Toy, Weiyi; Lin, Qingsong; Boon, Keong Ang; Chee, Hong Wong; Lim, Simin; Li, Bin; Hew, Choy Leong; Sze, Newman Siu Kwan; Druker, Brian J.; Lim, Yoon Pin.

In: Proteomics, Vol. 7, No. 14, 01.07.2007, p. 2384-2397.

Research output: Contribution to journalArticle

Chen, Y, Teck Yew, L, Choong, LY, Ray, RS, Tan, YL, Toy, W, Lin, Q, Boon, KA, Chee, HW, Lim, S, Li, B, Hew, CL, Sze, NSK, Druker, BJ & Lim, YP 2007, 'Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells', Proteomics, vol. 7, no. 14, pp. 2384-2397. https://doi.org/10.1002/pmic.200600968
Chen, Yunhao ; Teck Yew, Low ; Choong, Lee Yee ; Ray, Rajarshi Sankar ; Tan, Yee Ling ; Toy, Weiyi ; Lin, Qingsong ; Boon, Keong Ang ; Chee, Hong Wong ; Lim, Simin ; Li, Bin ; Hew, Choy Leong ; Sze, Newman Siu Kwan ; Druker, Brian J. ; Lim, Yoon Pin. / Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells. In: Proteomics. 2007 ; Vol. 7, No. 14. pp. 2384-2397.
@article{0a785ede0dad4e94b8aa80d6319c2d95,
title = "Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells",
abstract = "With the completion of the human genome project, analysis of enriched phosphotyrosyl proteins from epidermal growth factor (EGF)-induced phosphotyrosine proteome permits the identification of novel downstream substrates of the EGF receptor (EGFR). Using cICAT-based LC-MS/MS method, we identified and relatively quantified the tyrosine phosphorylation levels of 21 proteins between control and EGF-treated A431 human cervical cancer cells. Of these, Endofin, DCBLD2, and KIAA0582 were validated to be novel tyrosine-phosphorylation targets of EGF signaling and Iressa, a highly selective inhibitor of EGFR. In addition, EGFR activity was shown to be necessary for EGF-induced localization of Endofin, an FYVE domain-containing protein regulated by phosphoinositol lipid and engaged in endosome-mediated receptor modulation. Although several groups have conducted phosphoproteomics of EGF signaling in recent years, our study is the first to identify and validate Endofin, DCBLD2, and KIAA0582 as part of a complex EGF phosphotyrosine signaling network. These novel data will provide new insights into the complex EGF signaling and may have implications on target-directed cancer therapeutics.",
keywords = "cICAT, DCBLD2, EGF, Endofin, Iressa",
author = "Yunhao Chen and {Teck Yew}, Low and Choong, {Lee Yee} and Ray, {Rajarshi Sankar} and Tan, {Yee Ling} and Weiyi Toy and Qingsong Lin and Boon, {Keong Ang} and Chee, {Hong Wong} and Simin Lim and Bin Li and Hew, {Choy Leong} and Sze, {Newman Siu Kwan} and Druker, {Brian J.} and Lim, {Yoon Pin}",
year = "2007",
month = "7",
day = "1",
doi = "10.1002/pmic.200600968",
language = "English",
volume = "7",
pages = "2384--2397",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "14",

}

TY - JOUR

T1 - Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells

AU - Chen, Yunhao

AU - Teck Yew, Low

AU - Choong, Lee Yee

AU - Ray, Rajarshi Sankar

AU - Tan, Yee Ling

AU - Toy, Weiyi

AU - Lin, Qingsong

AU - Boon, Keong Ang

AU - Chee, Hong Wong

AU - Lim, Simin

AU - Li, Bin

AU - Hew, Choy Leong

AU - Sze, Newman Siu Kwan

AU - Druker, Brian J.

AU - Lim, Yoon Pin

PY - 2007/7/1

Y1 - 2007/7/1

N2 - With the completion of the human genome project, analysis of enriched phosphotyrosyl proteins from epidermal growth factor (EGF)-induced phosphotyrosine proteome permits the identification of novel downstream substrates of the EGF receptor (EGFR). Using cICAT-based LC-MS/MS method, we identified and relatively quantified the tyrosine phosphorylation levels of 21 proteins between control and EGF-treated A431 human cervical cancer cells. Of these, Endofin, DCBLD2, and KIAA0582 were validated to be novel tyrosine-phosphorylation targets of EGF signaling and Iressa, a highly selective inhibitor of EGFR. In addition, EGFR activity was shown to be necessary for EGF-induced localization of Endofin, an FYVE domain-containing protein regulated by phosphoinositol lipid and engaged in endosome-mediated receptor modulation. Although several groups have conducted phosphoproteomics of EGF signaling in recent years, our study is the first to identify and validate Endofin, DCBLD2, and KIAA0582 as part of a complex EGF phosphotyrosine signaling network. These novel data will provide new insights into the complex EGF signaling and may have implications on target-directed cancer therapeutics.

AB - With the completion of the human genome project, analysis of enriched phosphotyrosyl proteins from epidermal growth factor (EGF)-induced phosphotyrosine proteome permits the identification of novel downstream substrates of the EGF receptor (EGFR). Using cICAT-based LC-MS/MS method, we identified and relatively quantified the tyrosine phosphorylation levels of 21 proteins between control and EGF-treated A431 human cervical cancer cells. Of these, Endofin, DCBLD2, and KIAA0582 were validated to be novel tyrosine-phosphorylation targets of EGF signaling and Iressa, a highly selective inhibitor of EGFR. In addition, EGFR activity was shown to be necessary for EGF-induced localization of Endofin, an FYVE domain-containing protein regulated by phosphoinositol lipid and engaged in endosome-mediated receptor modulation. Although several groups have conducted phosphoproteomics of EGF signaling in recent years, our study is the first to identify and validate Endofin, DCBLD2, and KIAA0582 as part of a complex EGF phosphotyrosine signaling network. These novel data will provide new insights into the complex EGF signaling and may have implications on target-directed cancer therapeutics.

KW - cICAT

KW - DCBLD2

KW - EGF

KW - Endofin

KW - Iressa

UR - http://www.scopus.com/inward/record.url?scp=34547189602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547189602&partnerID=8YFLogxK

U2 - 10.1002/pmic.200600968

DO - 10.1002/pmic.200600968

M3 - Article

C2 - 17570516

AN - SCOPUS:34547189602

VL - 7

SP - 2384

EP - 2397

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 14

ER -